Role of islet amyloid in type 2 diabetes mellitus

International Journal of Biochemistry and Cell Biology

Volumn 38, Issue 5-6, 2006, Pages 726-736

  Höppener, Jo W M ^a   Lips, Cees J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cell failure; Insulin deficiency; Islet amyloid; Islet amyloid polypeptide; Type 2 diabetes mellitus

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; AMYLIN; AMYLOID; METFORMIN; POLYPEPTIDE; ROSIGLITAZONE;

CELL DAMAGE; CELL DEATH; FAMILIAL AMYLOIDOSIS; HEALTH CARE COST; HISTOPATHOLOGY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET; REVIEW;

AMYLOID; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS;

EID: 33644834054     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2005.12.009     Document Type: Review

References (96)

1. B. Ahrén Type 2 diabetes, insulin secretion and beta-cell mass Current Molecular Medicine 5 2005 275 286
2. J.B. Ancsin Amyloidogenesis: Historical and modern observations point to heparin sulfate proteoglycans as a major culprit Amyloid 10 2003 67 79
3. I. Barroso Genetics of type 2 diabetes Diabetic Medicine 22 2005 517 535
4. C. Betsholtz, L. Christmansson, U. Engstrom, F. Rorsman, V. Svensson, and K.H. Johnson Sequence divergence in a specific region of islet amyloid polypeptide (IAPP) explains difference in islet amyloid formation between species FEBS Letters 251 1989 261 264
5. D.R. Booth, M. Sunde, V. Bellotti, C.V. Robinson, W.L. Hutchinson, and P.E. Fraser Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis Nature 385 1997 787 793
6. M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, and J. Zurdo Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416 2002 507 511
7. J. Buteau, W. El-Assaad, C.J. Rhodes, L. Rosenberg, E. Joly, and M. Prentki Glucagon-like peptide-1 prevents beta cell glucolipotoxicity Diabetologia 47 2004 806 815
8. A.E. Butler, J. Jang, T. Gurlo, M.D. Carty, W.C. Soeller, and P.C. Butler Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat) Diabetes 53 2004 1509 1516
9. A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, and P.C. Butler Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes Diabetes 52 2003 102 110
10. A.E. Butler, J. Janson, W.C. Soeller, and P.C. Butler Increased β-cell apoptosis prevents adaptive increase in β-cell mass in mouse model of type 2 diabetes. Evidence for role of islet amyloid formation rather than direct action of amyloid Diabetes 52 2003 2304 2314
11. B. Caughey, and P.T. Lansbury Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders Annual Reviews in Neurosciences 26 2003 267 298
12. M.W. Cluck, C.Y. Chan, and T.E. Adrian The regulation of amylin and insulin gene expression and secretion Pancreas 30 2005 1 14
13. M. Cnop, N. Welsh, J.C. Jonas, A. Jorns, S. Lenzen, and D.L. Eizirik Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities Diabetes 54 Suppl. 2 2005 S97 S107
14. G.J.S. Cooper, A.C. Willis, A. Clark, R.C. Turner, R.B. Sim, and K.B. Reid Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients Proceedings of the National Academy of Sciences USA 84 1987 8628 8632
15. A. Costa, I. Conget, and R. Gomis Impaired glucose tolerance: Is there a case for pharmacologic intervention? Treatments in Endocrinology 1 2002 205 210
16. E.J. De Koning, N.L. Bodkin, B.C. Hansen, and A. Clark Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population Diabetologia 36 1993 378 384
17. S. Enoki, T. Mitsukawa, J. Takemura, M. Nakazato, J. Aburaya, and H. Toshimori Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus Diabetes Research and Clinical Practice 15 1992 97 102
18. M.S. German, L.G. Moss, J. Wang, and W.J. Rutter The insulin and islet amyloid polypeptide genes contain similar cell-specific promoter elements that bind identical beta-cell nuclear complexes Molecular and Cellular Biology 12 1992 1777 1788
19. J.D. Gillmore, P.N. Hawkins, and M.B. Pepys Amyloidosis: A review of recent diagnostic and therapeutic developments British Journal of Haematology 99 1997 245 256
20. G.G. Glenner Amyloid deposits and amyloidosis: The β-fibrilloses New England Journal of Medicine 302 1980 1283 1292
21. D.J. Gordon, J.J. Balbach, R. Tycko, and S.C. Meredith Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel Biophysical Journal 86 2004 428 434
22. G. Gulli, L. Rossetti, and R.A. DeFronzo Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents Metabolism 46 1997 1157 1161
23. C.E. Higham, R.L. Hull, L. Lawrie, K.I. Shennan, J.F. Morris, and N.P. Birch Processing of synthetic pro-islet amyloid polypeptide (proIAPP) 'amylin' by recombinant prohormone convertase enzymes, PC2 and PC3, in vitro European Journal of Biochemistry 267 2000 4998 5004
24. M. Hoenig, G. Hall, D. Ferguson, K. Jordan, M. Henson, and K.H. Johnson A feline model of experimentally induced islet amyloidosis American Journal of Pathology 157 2000 2143 2150
25. J.W.M. Höppener, B. Ahrén, and C.J.M. Lips Islet amyloid and type 2 diabetes mellitus New England Journal of Medicine 343 2000 411 419
26. J.W.M. Höppener, M.G. Nieuwenhuis, Th.M. Vroom, B. Ahrén, and C.J.M. Lips Role of islet amyloid in type 2 diabetes mellitus: Consequence or cause? Molecular and Cellular Endocrinology 197 2002 205 212
27. J.W.M. Höppener, M.G. Nieuwenhuis, Th.M. Vroom, and C.J.M. Lips Eilandjesamyloid en diabetes mellitus type 2 Nederlands Tijdschrift voor de Geneeskunde 42 2000 1995 2000
28. J.W.M. Höppener, C. Oosterwijk, M.G. Nieuwenhuis, G. Posthuma, J.H.H. Thijssen, and Th.M. Vroom Extensive islet amyloid formation is induced by development of type II diabetes mellitus and contributes to its progression: Pathogenesis of diabetes in a transgenic mouse model Diabetologia 42 1999 427 434
29. Höppener, J.W.M., Oosterwijk, C., Wierup, N., Jacobs, H.M., Nieuwenhuis, M.G., Lips, C.J.M., et al. Islet amyloid and glucose intolerance in high-fat fed mice transgenic for human islet amyloid polypeptide, unpublished results.
30. J.W.M. Höppener, J.S. Verbeek, E.J.P. De Koning, C. Oosterwijk, K.L. Van Hulst, and H.J. Visser-Vernooy Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: Lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycemia or hyperinsulinemia Diabetologia 36 1993 1258 1265
31. R.L. Hull, S. Andrikopoulos, C.B. Verchere, J. Vidal, F. Wang, and M. Cnop Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid Diabetes 52 2003 372 379
32. R.L. Hull, Z.P. Shen, M.R. Watts, K. Kodama, D.B. Carr, and K.M. Utzschneider Long-term treatment with rosiglitazone and metformin reduces the extent of, but does not prevent, islet amyloid deposition in mice expressing the gene for human islet amyloid polypeptide Diabetes 54 2005 2235 2244
33. S. Janciauskiene, and B. Ahrén Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines Biochemical and Biophysical Research Communications 267 2000 619 625
34. J. Janson, R.H. Ashley, D. Harrison, S. McIntyre, and P.C. Butler The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles Diabetes 48 1999 491 498
35. J. Janson, W.C. Soeller, P.C. Roche, R.T. Nelson, A.J. Torchia, and D.K. Kreutter Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide Proceedings of the National Academy of Sciences USA 93 1996 7283 7288
36. C. Janus, J. Pearson, J.A. McLaurin, P.M. Mathews, Y. Jiang, and S.D. Schmidt Aβ peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease Nature 408 2000 979 982
37. S.A. Jayasinghe, and R. Langen Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling Journal of Biological Chemistry 279 2004 48420 48425
38. K. Jordan, M.P. Murtaugh, T.D. O'Brien, P. Westermark, C. Betsholtz, and K.H. Johnson Canine IAPP cDNA sequence provides important clues regarding diabetogenesis and amyloidogenesis in type 2 diabetes Biochemical Biophysical Research Communications 169 1990 502 508
39. B.B. Kahn Type 2 diabetes: When insulin secretion fails to compensate for insulin resistance Cell 92 1998 593 596
40. N. Kaiser, G. Leibowitz, and R. Nesher Glucotoxicity and beta-cell failure in type 2 diabetes mellitus Journal of Pediatric Endocrinology and Metabolism 16 2003 5 22
41. R. Kayed, E. Head, J.L. Thompson, T.M. McIntyre, S.C. Milton, and C.W. Cotman Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis Science 300 2003 486 489
42. R. Kayed, Y. Sokolov, B. Edmonds, T.M. McIntyre, S.C. Milton, and J.E. Hall Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases Journal of Biological Chemistry 279 2004 46363 46366
43. J.H. Kim, P.M. Nishina, and J.K. Naggert Genetic models for non insulin dependent diabetes mellitus in rodents Journal of Basic and Clinical Physiology and Pharmacology 9 1998 325 345
44. R. Kisilevsky, W.A. Szarek, J. Ancsin, S. Bhat, Z. Li, and S. Marone Novel glycosaminoglycan precursors as anti-amyloid agents. Part III Journal of Molecular Neuroscience 20 2003 291 297
45. H. Larsson, and B. Ahrén Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance Diabetologia 9 1996 1099 1107
46. J.D. Leffert, C.B. Newgard, H. Okamoto, J.L. Milburn, and K.L. Luskey Rat amylin: Cloning and tissue-specific expression in pancreatic islets Proceedings of the National Academy of Sciences USA 86 1989 3127 3130
47. C. Lelliot, and A.J. Vidal-Puig Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation International Journal of Obesity 28 Suppl. 4 2004 S22 S28
48. P.P. Liberski, B. Sikorska, J. Bratosiewicz-Wasik, D.C. Gajdusek, and P. Brown Neuronal cell death in transmissible spongiform encephalopathies (prion diseases) revisited: From apoptosis to autophagy International Journal of Biochemistry and Cell Biology 36 2004 2473 2490
49. A. Lorenzo, B. Razzabon, G.C. Weir, and B.A. Yankner Pancreatic islet cell toxicity of amylin associated with type 2 diabetes mellitus Nature 368 1994 756 760
50. B. Ludvik, A. Kautzky Willer, R. Prager, K. Thomaseth, and G. Pacini Amylin: History and overview Diabetic Medicine 14 Suppl. 2 1997 S9 S13
51. L. Marzban, G. Trigo-Gonzalez, and C.B. Verchere Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of beta cells Molecular Endocrinology 19 2005 2154 2163
52. L. Marzban, G. Trigo-Gonzalez, X. Zhu, C.J. Rhodes, P.A. Halban, and D.F. Steiner Role of beta-cell prohormone convertase (PC) 1/3 in processing of pro-islet amyloid polypeptide Diabetes 53 2004 141 148
53. T.A. Mirzabekov, M.C. Lin, and B.L. Kagan Pore formation by the cytotoxic islet amyloid peptide amylin Journal of Biological Chemistry 271 1996 1988 1992
54. D. Morgan, D.M. Diamond, P.E. Gottschall, K.E. Ugen, C. Dickey, and J. Hardy Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 2000 982 985
55. S. Mosselman, J.W.M. Höppener, J. Zandberg, A.D.M. Van Mansfeld, A.H.M. Geurts van Kessel, and C.J.M. Lips Islet amyloid polypeptide: Identification and chromosomal localization of the human gene FEBS Letters 239 1988 227 232
56. J.E. Murphy, S. Zhou, K. Giese, L.T. Williams, J.A. Escobedo, and V.J. Dwarki Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin Proceedings of the National Academy of Sciences USA 94 1997 13921 13926
57. M. Nishi, S.J. Chan, S. Nagamatsu, G.I. Bell, and D.F. Steiner Conservation of the sequence of islet amyloid polypeptide in five mammals is consistent with its putative role as an islet hormone Proceedings of the National Academy of Sciences USA 86 1989 5738 5742
58. T.D. O'Brien Pathogenesis of feline diabetes mellitus Molecular and Cellular Endocrinology 197 2002 213 219
59. T.D. O'Brien, J.D. Wagner, K.N. Litwak, C.S. Carlson, W.T. Cefalu, and K. Jordan Islet amyloid and islet amyloid polypeptide in cynomolgus macaques (Macaca fascicularis): An animal model of human non-insulin-dependent diabetes mellitus Veterinary Pathology 33 1996 479 485
60. T.D. O'Brien, P. Westermark, and K.H. Johnson Islet amyloid polypeptide and calcitonin gene-related peptide immunoreactivity in amyloid and tumor cells of canine pancreatic endocrine tumors Veterinary Pathology 27 1990 194 198
61. E.L. Opie The relation of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of langerhans Journal of Experimental Medicine 5 1901 527 540
62. H. Pardes, K.G. Manton, E.S. Lander, H.D. Tolley, A.D. Ullian, and H. Palmer Effects of medical research on health care and economy Science 283 1999 36 37
63. K. Park, and C.B. Verchere Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. Implications for islet amyloid formation Journal of Biological Chemistry 276 2001 16611 16616
64. J.F. Paulsson, and G.T. Westermark Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formation Diabetes 54 2005 2117 2125
65. M.B. Pepys, J. Herbert, W.L. Hutchinson, G.A. Tennent, H.J. Lachmann, and J.R. Gallimore Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis Nature 417 2002 254 259
66. M. Prentki, E. Joly, W. El-Assaad, and R. Roduit Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: Role in beta-cell adaptation and failure in the etiology of diabetes Diabetes 51 Suppl. 3 2002 S405 S413
67. J. Rand Current understanding of feline diabetes. Part 1. Pathogenesis Journal of Feline Medicine and Surgery 1 1999 143 153
68. C.J. Rhodes Type 2 diabetes - a matter of β-cell life and death Science 307 2005 380 384
69. D.T. Rijkers, J.W.M. Höppener, G. Posthuma, C.J.M. Lips, and R.M. Liskamp Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides Chemistry 8 2002 4285 4291
70. R.P. Robertson Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes Journal of Biological Chemistry 279 2004 42351 42354
71. L. Rosenfeld Insulin: Discovery and controversy Clinical Chemistry 48 2002 2270 2288
72. J. Roth, X. Qiang, S.L. Marban, H. Redelt, and B.C. Lowell The obesity pandemic: Where have we been and where are we going? Obesity Research 12 2004 88S 101S
73. F. Rotondo, S. Vidal, D. Bell, E. Horvath, K. Kovacs, and B.W. Scheithauer Immunohistochemical localization of amylin in human pancreas, thyroid, pituitary and their tumors Acta Histochemica 105 2003 303 307
74. J.E. Schaffer Lipotoxicity: When tissues overeat Current Opinion in Lipidology 14 2003 281 287
75. D.J. Selkoe Towards a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein Annals of the New York Academy of Sciences 924 2000 17 25
76. W.C. Soeller, J. Janson, S.E. Hart, J.C. Parker, M.D. Carty, and R.W. Stevenson Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide Diabetes 47 1998 743 750
77. J.D. Sorkin, D.C. Muller, J.L. Fleg, and R. Andres The relation of fasting and 2-h postchallenge plasma glucose concentrations to mortality: Data from the Baltimore Longitudinal Study of Aging with a critical review of the literature Diabetes Care 28 2005 2626 2632
78. M. Stumvoll, B.J. Goldstein, and T.W. Van Haeften Type 2 diabetes: Principles of pathogenesis and therapy Lancet 365 2005 1333 1346
79. D. Tsakiris, and K. Ioannou An underdiagnosed type of diabetes: The MODY syndromes. Pathophysiology, clinical presentation and renal disease progression Journal of Nephrology 17 2004 637 641
80. K.L. Van Hulst, C. Oosterwijk, W. Born, Th.M. Vroom, M.G. Nieuwenhuis, and M.A. Blankenstein Islet amyloid polypeptide (IAPP)/amylin messenger RNA and protein expression in human insulinomas: Relation to amyloid formation European Journal of Endocrinology 140 1999 69 78
81. C.B. Verchere, D.A. D'Alesssio, R.D. Palmiter, G.C. Weir, S. Bonner-Weir, and D.G. Baskin Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide Proceedings of the National Academy of Sciences USA 93 1996 3492 3496
82. R. Virchow Über eine im Gehirn und Rückenmark des Menschen aufgefundene Substanz mit der chemischen Reaction der Cellulose Archives of Pathological Anatomy and Physiology and Clinical Medicine 6 1854 135 138
83. J.D. Wagner, J.M. Cline, M.K. Shadoan, B.C. Bullock, S.E. Rankin, and W.T. Cefalu Naturally occurring and experimental diabetes in cynomolgus monkeys: A comparison of carbohydrate and lipid metabolism and islet pathology Toxicologic Pathology 29 2001 142 148
84. H. Walter, and G. Lubben Potential role of oral thiazolidinedione therapy in preserving beta-cell function in type 2 diabetes mellitus Drugs 65 2005 1 13
85. J. Wang, J. Xu, J. Finnerty, M. Furuta, D.F. Steiner, and C.B. Verchere The prohormone convertase enzyme 2 (PC2) is essential for processing pro-islet amyloid polypeptide at the NH2-terminal cleavage site Diabetes 50 2001 534 539
86. P. Westermark Amyloid and polypeptide hormones: What is their relationship? Amyloid: The International Journal of Experimental and Clinical Investigation 1 1994 47 60
87. P. Westermark, U. Engström, K.H. Johnson, G.T. Westermark, and C. Betsholtz Islet amyloid polypeptide: Pinpointing amino acid residues linked to amyloid fibril formation Proceedings of the National Academy of Sciences USA 87 1990 5036 5040
88. G.T. Westermark, D.F. Steiner, S. Gebre-Medhin, U. Engstrom, and P. Westermark Pro islet amyloid polypeptide (ProIAPP) immunoreactivity in the islets of Langerhans Upsala Journal of Medical Sciences 105 2000 978 1006
89. P. Westermark, C. Wernstedt, E. Wilander, D.W. Hayden, T.D. O'Brien, and K.H. Johnson Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells Proceedings of the National Academy of Sciences USA 84 1987 3881 3885
90. P. Westermark, C. Wernstedt, E. Wilander, and K. Sletten A novel peptide in the calcitonin gene related peptide family as an amyloid fibrilprotein in the endocrine pancreas Biochemical Biophysical Research Communications 140 1986 827 831
91. C. Weyer, T. Funahashi, S. Tanaka, K. Hotta, Y. Matsuzawa, and R.E. Pratley Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia Journal of Clinical Endocrinology and Metabolism 86 2001 1930 1935
92. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030 Diabetes Care 27 2004 1047 1053
93. G. Wolf Insulin resistance and obesity: Resistin, a hormone secreted by adipose tissue Nutrition Reviews 62 2004 389 394
94. S. Zhang, J. Liu, M. Dragunow, and G.J.S. Cooper Fibrillogenic amylin evokes islet beta-cell apoptosis through linked activation of a caspase cascade and JNK1 Journal of Biological Chemistry 278 2003 52810 52819
95. H.L. Zhao, F.M. Lai, P.C. Tong, D.R. Zhong, D. Yang, and B. Tomlinson Prevalence and clinicopathological characteristics of islet amyloid in chinese patients with type 2 diabetes Diabetes 52 2003 2759 2766
96. P. Zimmet The burden of type 2 diabetes: Are we doing enough? Diabetes and Metabolism 29 2003 6S9 6S18